Research advances of multi-targeted flavonoids in the intervention of Alzheimer′s disease

YUAN Lijuan; WANG Keren; SANG Zhipei

doi:10.11665/j.issn.1000-5048.20180102

Journal of China Pharmaceutical University > 2018 > 49(1): 10-19. > DOI: 10.11665/j.issn.1000-5048.20180102

YUAN Lijuan, WANG Keren, SANG Zhipei. Research advances of multi-targeted flavonoids in the intervention of Alzheimer′s disease[J]. Journal of China Pharmaceutical University, 2018, 49(1): 10-19. DOI: 10.11665/j.issn.1000-5048.20180102

Citation:

PDF (1102 KB)

Research advances of multi-targeted flavonoids in the intervention of Alzheimer′s disease

More Information

Graphical Abstract

Abstract

Abstract

Alzheimer′s disease(AD)is a chronic progressive neurodegenerative disease in the elderly, which causes heavy burden for the society and family. The current drugs could only improve the cognitive symptoms in the short term, but could not reverse or stop the disease progression. In view of the complexity of AD, multi-targeted drugs could be a potential strategy for the treatment of AD. Flavonoids, widely exising in the natural world, have multiple pharmacological activities. This paper summarizes flavonoids as promising multi-targeted anti-AD candidates according to the reported references previonsly published, which could provide important evidences in the development of anti-AD durgs.
- Alzheimer′s disease,
- multi-target directed ligands,
- flavonoids

FullText(HTML)

References (31)

References

[1]	Alzheimer′s Disease International.Policy brief:the global impact of dementia 2013-2050[EB/OL].http://www.alz.co.uk/research/G8-policy-brief.
[2]	Alzheimer′s Disease International.World Alzheimer report 2015:the global impact of dementia[EB/OL].https://www.alz.co.uk/research/world-report-2015.
[3]	Guo JJ,Liao H.Development of drug for Alzheimer′s disease [J].J China Pharm Univ(中国药科大学学报),2010,41(5):395-400.
[4]	Citron M.Alzheimer′s disease:strategies for disease modification [J].Nat Rev Drug Discov,2010,9(5):387-398.
[5]	Cavalli A,Bolognesi ML,Minarini A,et al.Multi-target-directed ligands to combat neurodegenerative diseases [J].J Med Chem,2008,51(3):347-372.
[6]	De Freitas Silva M, Dias KST, Gontijo VS, et al. Multi-target directed drug as a modern approach for drug design toward Alzheimer′s disease:an update [J].Curr Med Chem,2018.doi: 10.2174/0929867325666180111101843.
[7]	Chen X, Mukwaya E, Wong MS, et al. A systematic review on biological activities of prenylated flavonoids[J].Pharm Biol,2014,52(5):655-660.
[8]	Sheng R,Lin X,Zhang J,et al.Design,synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors[J].Bioorg Med Chem,2009,17(18):6692-6698.
[9]	Luo W,Su YB,Hong C,et al.Design,synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents[J].Bioorg Med Chem,2013,21(23):7275-7282.
[10]	Li RS,Wang XB,Hu XJ,et al.Design,synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer′s disease[J].Bioorg Med Chem Lett,2013,23(9):2636-2641.
[11]	Li SY,Wang XB,Xie SS,et al.Multifunctional tacrine-flavonoid hybrids with cholinergic,beta-amyloid-reducing,and metal chelating properties for the treatment of Alzheimer′s disease[J].Eur J Med Chem,2013,69:632-646.
[12]	Sang Z,Li Y,Qiang X,et al.Multifunctional scutellarin-rivastigmine hybrids with cholinergic,antioxidant,biometal chelating and neuroprotective properties for the treatment of Alzheimer′s disease[J]. Bioorg Med Chem,2015,23(4):668-680.
[13]	Sang ZP,Qiang XM,Li Y,et al.Design,synthesis,and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer′s disease[J]. Chem Biol Drug Des,2015,86(5):1168-1177.
[14]	Sang Z,Qiang X,Li Y,et al.Design,synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer′s disease[J]. Eur J Med Chem,2015,94:348-366.
[15]	Sang Z,Qiang X,Li Y,et al.Design,synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer′s disease[J]. Eur J Med Chem,2017,135:307-323.
[16]	Shi DH,Yan ZQ,Zhang LN,et al.A novel 7-O-modified derivative with acetylcholinesterase inhibitory effect,estrogenic activity and neuroprotective effect[J].Arch Pharm Res,2012,35(9):1645-1654.
[17]	Qiang X,Yuan W,Sang Z,et al.Synthesis and biological evaluation of genistein carbamate derivatives[J].Chin J Org Chem(有机化学),2013,33(3):621-629.
[18]	Qiang X,Sang Z,Yuan W,et al.Design,synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer′s disease[J]. Eur J Med Chem,2014,76:314-331.
[19]	Chen YP, Zhang ZY, Li YP, et al. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase[J].Eur J Med Chem,2013,66:22-31.
[20]	Rampa A,Montanari S,Pruccoli L,et al.Chalcone-based carbamates for Alzheimer′s disease treatment [J].Future Med Chem,2017,9(8):749-764.
[21]	Jeon KH,Lee E,Jun KY,et al.Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble Aβ peptide formation [J].Eur J Med Chem,2016,121:433-444.
[22]	Wang L,Wang Y,Tian Y,et al.Design,synthesis,biological evaluation,and molecular modeling studies of chalcone-rivastigmine hybrids as cholinesterase inhibitors [J].Bioorg Med Chem,2017,25(1):360-371.
[23]	Xiao G, Li Y, Qiang X, et al. Design,synthesis and biological evaluation of 4′-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer′s disease [J].Bioorg Med Chem,2017,25(3):1030-1041.
[24]	Belluti F,Rampa A,Piazzi L,et al.Cholinesterase inhibitors:xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation [J].J Med Chem,2005,48(13):4444-4456.
[25]	Li Y,Qiang X,Luo L,et al.Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer′s disease [J].Bioorg Med Chem,2016,24(10):2342-2351.
[26]	Li Y,Qiang X,Luo L,et al.Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition,anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer′s disease [J].Eur J Med Chem,2017,126:762-755.
[27]	Javed H,Vaibhav K,Ahmed ME,et al.Effect of hesperidin on neurobehavioral,neuroinflammation,oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice[J].J Neurol Sci,2015,348(1/2):51-59.
[28]	Chen X,Zenger K,Lupp A,et al.Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo[J].J Med Chem,2012,55(11):5231-5242.
[29]	Li Y,Qiang X,Luo L,et al.Multitarget drug design strategy against Alzheimer′s disease:homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties[J]. Bioorg Med Chem,2017,25(2):714-726.
[30]	Luo L,Li Y,Qiang X,et al.Multifunctional thioxanthone derivatives with acetylcholinesterase,monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer′s disease[J]. Bioorg Med Chem,2017,25(6):1997-2009.
[31]	Wang SN,Li Q,Jing MH,et al.Natural xanthones from Garcinia mangostana with multifunctional activities for the therapy of Alzheimer′s disease[J].Neurochem Res,2016,41(7):1806-1817.

Cited By

Get Citation

PDF

XML

Article views (1415) PDF downloads (1890)

Turn off MathJax

Article Contents

Abstract

References

Research advances of multi-targeted flavonoids in the intervention of Alzheimer′s disease

Abstract

References

Catalog

Export File

Citation

Format

Content